Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases

Arturo Casadevall, Liise Anne Pirofski

Research output: Contribution to journalArticle

Abstract

Only two decades ago antibodies to fungi were thought to have little or no role in protection against fungal diseases. However, subsequent research has provided convincing evidence that certain antibodies can modify the course of fungal infection to the benefit or detriment of the host. Hybridoma technology was the breakthrough that enabled the characterization of antibodies to fungi, illuminating some of the requirements for antibody efficacy. As discussed in this review, fungal-specific antibodies mediate protection through direct actions on fungal cells and through classical mechanisms such as phagocytosis and complement activation. Although mechanisms of antibody-mediated protection are often species-specific, numerous fungal antigens can be targeted to generate vaccines and therapeutic immunoglobulins. Furthermore, the study of antibody function against medically important fungi has provided fresh immunological insights into the complexity of humoral immunity that are likely to apply to other pathogens.

Original languageEnglish (US)
Pages (from-to)447-456
Number of pages10
JournalCell Host and Microbe
Volume11
Issue number5
DOIs
StatePublished - May 17 2012
Externally publishedYes

Fingerprint

Mycoses
Immunoglobulins
Antibodies
Fungi
Fungal Antibodies
Fungal Antigens
Therapeutics
Complement Activation
Hybridomas
Humoral Immunity
Phagocytosis
Vaccines
Technology
Research

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Cancer Research
  • Molecular Biology

Cite this

Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. / Casadevall, Arturo; Pirofski, Liise Anne.

In: Cell Host and Microbe, Vol. 11, No. 5, 17.05.2012, p. 447-456.

Research output: Contribution to journalArticle

@article{f250a6c1f8d3440793b770f0fa9a3e35,
title = "Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases",
abstract = "Only two decades ago antibodies to fungi were thought to have little or no role in protection against fungal diseases. However, subsequent research has provided convincing evidence that certain antibodies can modify the course of fungal infection to the benefit or detriment of the host. Hybridoma technology was the breakthrough that enabled the characterization of antibodies to fungi, illuminating some of the requirements for antibody efficacy. As discussed in this review, fungal-specific antibodies mediate protection through direct actions on fungal cells and through classical mechanisms such as phagocytosis and complement activation. Although mechanisms of antibody-mediated protection are often species-specific, numerous fungal antigens can be targeted to generate vaccines and therapeutic immunoglobulins. Furthermore, the study of antibody function against medically important fungi has provided fresh immunological insights into the complexity of humoral immunity that are likely to apply to other pathogens.",
author = "Arturo Casadevall and Pirofski, {Liise Anne}",
year = "2012",
month = "5",
day = "17",
doi = "10.1016/j.chom.2012.04.004",
language = "English (US)",
volume = "11",
pages = "447--456",
journal = "Cell Host and Microbe",
issn = "1931-3128",
publisher = "Cell Press",
number = "5",

}

TY - JOUR

T1 - Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases

AU - Casadevall, Arturo

AU - Pirofski, Liise Anne

PY - 2012/5/17

Y1 - 2012/5/17

N2 - Only two decades ago antibodies to fungi were thought to have little or no role in protection against fungal diseases. However, subsequent research has provided convincing evidence that certain antibodies can modify the course of fungal infection to the benefit or detriment of the host. Hybridoma technology was the breakthrough that enabled the characterization of antibodies to fungi, illuminating some of the requirements for antibody efficacy. As discussed in this review, fungal-specific antibodies mediate protection through direct actions on fungal cells and through classical mechanisms such as phagocytosis and complement activation. Although mechanisms of antibody-mediated protection are often species-specific, numerous fungal antigens can be targeted to generate vaccines and therapeutic immunoglobulins. Furthermore, the study of antibody function against medically important fungi has provided fresh immunological insights into the complexity of humoral immunity that are likely to apply to other pathogens.

AB - Only two decades ago antibodies to fungi were thought to have little or no role in protection against fungal diseases. However, subsequent research has provided convincing evidence that certain antibodies can modify the course of fungal infection to the benefit or detriment of the host. Hybridoma technology was the breakthrough that enabled the characterization of antibodies to fungi, illuminating some of the requirements for antibody efficacy. As discussed in this review, fungal-specific antibodies mediate protection through direct actions on fungal cells and through classical mechanisms such as phagocytosis and complement activation. Although mechanisms of antibody-mediated protection are often species-specific, numerous fungal antigens can be targeted to generate vaccines and therapeutic immunoglobulins. Furthermore, the study of antibody function against medically important fungi has provided fresh immunological insights into the complexity of humoral immunity that are likely to apply to other pathogens.

UR - http://www.scopus.com/inward/record.url?scp=84861168204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861168204&partnerID=8YFLogxK

U2 - 10.1016/j.chom.2012.04.004

DO - 10.1016/j.chom.2012.04.004

M3 - Article

C2 - 22607798

AN - SCOPUS:84861168204

VL - 11

SP - 447

EP - 456

JO - Cell Host and Microbe

JF - Cell Host and Microbe

SN - 1931-3128

IS - 5

ER -